Exagen's average Accounts Receivable for the
three
months ended in Dec. 2023 was $11.80 Mil. Exagen's Revenue for the
three
months ended in Dec. 2023 was $13.77 Mil.
Hence, Exagen's Days Sales Outstanding for the
three
months ended in Dec. 2023 was 78.21.
The historical rank and industry rank for Exagen's Days Sales Outstanding or its related term are showing as below:
XGN'
s Days Sales Outstanding Range Over the Past 10 Years
Min: 1.69 Med: 43.86 Max: 76.7
Current: 76.7
During the past 11 years, Exagen's highest Days Sales Outstanding was 76.70. The lowest was 1.69. And the median was 43.86.
XGN's Days Sales Outstanding is ranked worse than 56.25% of 224
companies
in the Medical Diagnostics & Research industry
Industry Median: 69.415
vs XGN: 76.70
Exagen's Days Sales Outstanding
increased
from Dec. 2022 (59.41) to Dec. 2023 (78.21).
Exagen Days Sales Outstanding Historical Data
The historical data trend for Exagen's Days Sales Outstanding can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Exagen's Days Sales Outstanding
For the Diagnostics & Research subindustry, Exagen's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Exagen's Days Sales Outstanding Distribution in the Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Exagen's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where Exagen's Days Sales Outstanding falls into.
Exagen Days Sales Outstanding Calculation
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Exagen (NAS:XGN) Days Sales Outstanding Explanation
For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.
Exagen Days Sales Outstanding Related Terms
Thank you for viewing the detailed overview of Exagen's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.
Exagen Inc is a commercial-stage diagnostics company committed to addressing the unmet need for the accurate diagnosis and monitoring of patients affected by autoimmune rheumatic diseases. It currently markets ten testing products under its Avise brand to provide an accurate, timely, and differential diagnosis and to optimize the treatment of ARDs. It markets and sells solutions to community rheumatologists.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
XGN has been successfully added to your 